nodes	percent_of_prediction	percent_of_DWPC	metapath
Aminocaproic Acid—AOX1—Methotrexate—bone cancer	0.57	1	CbGbCtD
Aminocaproic Acid—PLAT—amb2 Integrin signaling—MST1R—bone cancer	0.0378	0.108	CbGpPWpGaD
Aminocaproic Acid—PLG—amb2 Integrin signaling—MST1R—bone cancer	0.0378	0.108	CbGpPWpGaD
Aminocaproic Acid—PLAT—Folate Metabolism—FOLR1—bone cancer	0.018	0.0517	CbGpPWpGaD
Aminocaproic Acid—PLG—Folate Metabolism—FOLR1—bone cancer	0.018	0.0517	CbGpPWpGaD
Aminocaproic Acid—PLAT—Dissolution of Fibrin Clot—PLAU—bone cancer	0.0101	0.0289	CbGpPWpGaD
Aminocaproic Acid—PLG—Dissolution of Fibrin Clot—PLAU—bone cancer	0.0101	0.0289	CbGpPWpGaD
Aminocaproic Acid—PLG—Blood Clotting Cascade—PLAU—bone cancer	0.00662	0.019	CbGpPWpGaD
Aminocaproic Acid—PLAT—Blood Clotting Cascade—PLAU—bone cancer	0.00662	0.019	CbGpPWpGaD
Aminocaproic Acid—PLAT—Senescence and Autophagy in Cancer—BMI1—bone cancer	0.00653	0.0187	CbGpPWpGaD
Aminocaproic Acid—PLG—Orphan transporters—TUBB4B—bone cancer	0.00612	0.0175	CbGpPWpGaD
Aminocaproic Acid—PLAT—Orphan transporters—TUBB4B—bone cancer	0.00612	0.0175	CbGpPWpGaD
Aminocaproic Acid—PLG—Regulation of IGF Activity by IGFBP—MMP2—bone cancer	0.00542	0.0155	CbGpPWpGaD
Aminocaproic Acid—PLAT—Beta2 integrin cell surface interactions—PLAU—bone cancer	0.00531	0.0152	CbGpPWpGaD
Aminocaproic Acid—PLG—Orphan transporters—TUBB2A—bone cancer	0.00528	0.0151	CbGpPWpGaD
Aminocaproic Acid—PLAT—Orphan transporters—TUBB2A—bone cancer	0.00528	0.0151	CbGpPWpGaD
Aminocaproic Acid—PLG—Folate Metabolism—DHFR—bone cancer	0.00495	0.0142	CbGpPWpGaD
Aminocaproic Acid—PLAT—Folate Metabolism—DHFR—bone cancer	0.00495	0.0142	CbGpPWpGaD
Aminocaproic Acid—PLG—amb2 Integrin signaling—PLAU—bone cancer	0.00491	0.0141	CbGpPWpGaD
Aminocaproic Acid—PLAT—amb2 Integrin signaling—PLAU—bone cancer	0.00491	0.0141	CbGpPWpGaD
Aminocaproic Acid—PLG—Extracellular matrix organization—PLOD2—bone cancer	0.00451	0.0129	CbGpPWpGaD
Aminocaproic Acid—PLG—Platelet degranulation—SPARC—bone cancer	0.00434	0.0124	CbGpPWpGaD
Aminocaproic Acid—PLG—Response to elevated platelet cytosolic Ca2+—SPARC—bone cancer	0.00413	0.0118	CbGpPWpGaD
Aminocaproic Acid—AOX1—Tryptophan metabolism—CYP3A4—bone cancer	0.00409	0.0117	CbGpPWpGaD
Aminocaproic Acid—PLG—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—PLAU—bone cancer	0.00395	0.0113	CbGpPWpGaD
Aminocaproic Acid—PLG—Activation of Matrix Metalloproteinases—MMP2—bone cancer	0.00387	0.0111	CbGpPWpGaD
Aminocaproic Acid—PLAT—amb2 Integrin signaling—MMP2—bone cancer	0.00387	0.0111	CbGpPWpGaD
Aminocaproic Acid—PLG—amb2 Integrin signaling—MMP2—bone cancer	0.00387	0.0111	CbGpPWpGaD
Aminocaproic Acid—PLAT—Senescence and Autophagy in Cancer—SPARC—bone cancer	0.00349	0.00999	CbGpPWpGaD
Aminocaproic Acid—PLAT—Endochondral Ossification—IGF1R—bone cancer	0.00346	0.00991	CbGpPWpGaD
Aminocaproic Acid—PLAT—Complement and Coagulation Cascades—PLAU—bone cancer	0.00301	0.00862	CbGpPWpGaD
Aminocaproic Acid—PLG—Complement and Coagulation Cascades—PLAU—bone cancer	0.00301	0.00862	CbGpPWpGaD
Aminocaproic Acid—PLAT—amb2 Integrin signaling—MMP9—bone cancer	0.00291	0.00833	CbGpPWpGaD
Aminocaproic Acid—PLG—Activation of Matrix Metalloproteinases—MMP9—bone cancer	0.00291	0.00833	CbGpPWpGaD
Aminocaproic Acid—PLG—Syndecan-4-mediated signaling events—MMP9—bone cancer	0.00291	0.00833	CbGpPWpGaD
Aminocaproic Acid—PLG—amb2 Integrin signaling—MMP9—bone cancer	0.00291	0.00833	CbGpPWpGaD
Aminocaproic Acid—AOX1—Defective AMN causes hereditary megaloblastic anemia 1—DHFR—bone cancer	0.0029	0.00831	CbGpPWpGaD
Aminocaproic Acid—PLAT—Senescence and Autophagy in Cancer—IL3—bone cancer	0.00289	0.00829	CbGpPWpGaD
Aminocaproic Acid—PLAT—Endochondral Ossification—PLAU—bone cancer	0.00282	0.00808	CbGpPWpGaD
Aminocaproic Acid—PLG—Angiopoietin receptor Tie2-mediated signaling—MMP2—bone cancer	0.00271	0.00776	CbGpPWpGaD
Aminocaproic Acid—PLG—Metabolism of proteins—MOGS—bone cancer	0.00248	0.0071	CbGpPWpGaD
Aminocaproic Acid—PLG—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—MMP9—bone cancer	0.00234	0.0067	CbGpPWpGaD
Aminocaproic Acid—Necrosis—Cisplatin—bone cancer	0.00234	0.0288	CcSEcCtD
Aminocaproic Acid—PLAT—Senescence and Autophagy in Cancer—IGF1R—bone cancer	0.00233	0.00667	CbGpPWpGaD
Aminocaproic Acid—PLG—Extracellular matrix organization—LOX—bone cancer	0.00223	0.00638	CbGpPWpGaD
Aminocaproic Acid—PLG—Platelet activation, signaling and aggregation—SPARC—bone cancer	0.00192	0.00551	CbGpPWpGaD
Aminocaproic Acid—Myositis—Epirubicin—bone cancer	0.00192	0.0236	CcSEcCtD
Aminocaproic Acid—Pain—Carboplatin—bone cancer	0.00191	0.0235	CcSEcCtD
Aminocaproic Acid—PLAT—Senescence and Autophagy in Cancer—PLAU—bone cancer	0.0019	0.00544	CbGpPWpGaD
Aminocaproic Acid—PLG—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—EGFR—bone cancer	0.00189	0.00542	CbGpPWpGaD
Aminocaproic Acid—AOX1—Tryptophan metabolism—MDM2—bone cancer	0.00188	0.00539	CbGpPWpGaD
Aminocaproic Acid—Myositis—Doxorubicin—bone cancer	0.00178	0.0219	CcSEcCtD
Aminocaproic Acid—PLG—Platelet activation, signaling and aggregation—GNA11—bone cancer	0.00176	0.00504	CbGpPWpGaD
Aminocaproic Acid—PLG—Degradation of the extracellular matrix—MMP2—bone cancer	0.00171	0.00489	CbGpPWpGaD
Aminocaproic Acid—Local reaction—Epirubicin—bone cancer	0.0017	0.0209	CcSEcCtD
Aminocaproic Acid—PLAT—Endochondral Ossification—MMP9—bone cancer	0.00167	0.00479	CbGpPWpGaD
Aminocaproic Acid—PLG—Extracellular matrix organization—SPARC—bone cancer	0.00167	0.00478	CbGpPWpGaD
Aminocaproic Acid—PLG—Platelet activation, signaling and aggregation—IL3—bone cancer	0.00159	0.00457	CbGpPWpGaD
Aminocaproic Acid—PLAT—Senescence and Autophagy in Cancer—BRAF—bone cancer	0.00159	0.00455	CbGpPWpGaD
Aminocaproic Acid—Local reaction—Doxorubicin—bone cancer	0.00157	0.0194	CcSEcCtD
Aminocaproic Acid—PLAT—Senescence and Autophagy in Cancer—RB1—bone cancer	0.00156	0.00447	CbGpPWpGaD
Aminocaproic Acid—PLG—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.00149	0.00428	CbGpPWpGaD
Aminocaproic Acid—PLAT—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.00149	0.00428	CbGpPWpGaD
Aminocaproic Acid—PLG—Selenium Micronutrient Network—PTGS2—bone cancer	0.00148	0.00423	CbGpPWpGaD
Aminocaproic Acid—PLAT—Selenium Micronutrient Network—PTGS2—bone cancer	0.00148	0.00423	CbGpPWpGaD
Aminocaproic Acid—Nasal congestion—Cisplatin—bone cancer	0.00146	0.018	CcSEcCtD
Aminocaproic Acid—Anaphylactoid reaction—Cisplatin—bone cancer	0.00138	0.0169	CcSEcCtD
Aminocaproic Acid—Cerebrovascular accident—Cisplatin—bone cancer	0.00136	0.0167	CcSEcCtD
Aminocaproic Acid—PLG—Metabolism of proteins—TUBB4B—bone cancer	0.00136	0.00389	CbGpPWpGaD
Aminocaproic Acid—Thrombosis—Epirubicin—bone cancer	0.00133	0.0164	CcSEcCtD
Aminocaproic Acid—PLAT—Senescence and Autophagy in Cancer—MDM2—bone cancer	0.00133	0.00381	CbGpPWpGaD
Aminocaproic Acid—PLG—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.00129	0.00369	CbGpPWpGaD
Aminocaproic Acid—PLAT—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.00129	0.00369	CbGpPWpGaD
Aminocaproic Acid—PLG—Degradation of the extracellular matrix—MMP9—bone cancer	0.00128	0.00368	CbGpPWpGaD
Aminocaproic Acid—Necrosis—Methotrexate—bone cancer	0.00128	0.0158	CcSEcCtD
Aminocaproic Acid—Thrombosis—Doxorubicin—bone cancer	0.00123	0.0152	CcSEcCtD
Aminocaproic Acid—Necrosis—Epirubicin—bone cancer	0.0012	0.0148	CcSEcCtD
Aminocaproic Acid—PLG—Metabolism of proteins—TUBB2A—bone cancer	0.00117	0.00336	CbGpPWpGaD
Aminocaproic Acid—PLAT—Senescence and Autophagy in Cancer—JUN—bone cancer	0.00116	0.00331	CbGpPWpGaD
Aminocaproic Acid—Necrosis—Doxorubicin—bone cancer	0.00111	0.0137	CcSEcCtD
Aminocaproic Acid—PLAT—Folate Metabolism—TP53—bone cancer	0.00111	0.00317	CbGpPWpGaD
Aminocaproic Acid—PLG—Folate Metabolism—TP53—bone cancer	0.00111	0.00317	CbGpPWpGaD
Aminocaproic Acid—Delirium—Epirubicin—bone cancer	0.0011	0.0135	CcSEcCtD
Aminocaproic Acid—AOX1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—bone cancer	0.00109	0.00312	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling by PDGF—KIT—bone cancer	0.00109	0.00311	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling by PDGF—KIT—bone cancer	0.00109	0.00311	CbGpPWpGaD
Aminocaproic Acid—PLG—p75(NTR)-mediated signaling—TP53—bone cancer	0.00107	0.00306	CbGpPWpGaD
Aminocaproic Acid—Lacrimation increased—Epirubicin—bone cancer	0.00102	0.0126	CcSEcCtD
Aminocaproic Acid—Delirium—Doxorubicin—bone cancer	0.00101	0.0125	CcSEcCtD
Aminocaproic Acid—Renal failure—Cisplatin—bone cancer	0.00101	0.0124	CcSEcCtD
Aminocaproic Acid—Pulmonary embolism—Methotrexate—bone cancer	0.00101	0.0124	CcSEcCtD
Aminocaproic Acid—PLG—Hemostasis—SPARC—bone cancer	0.000991	0.00284	CbGpPWpGaD
Aminocaproic Acid—PLAT—Hemostasis—SPARC—bone cancer	0.000991	0.00284	CbGpPWpGaD
Aminocaproic Acid—Lacrimation increased—Doxorubicin—bone cancer	0.000946	0.0116	CcSEcCtD
Aminocaproic Acid—Pulmonary embolism—Epirubicin—bone cancer	0.000942	0.0116	CcSEcCtD
Aminocaproic Acid—Bradycardia—Cisplatin—bone cancer	0.000938	0.0115	CcSEcCtD
Aminocaproic Acid—Injection site reaction—Epirubicin—bone cancer	0.000936	0.0115	CcSEcCtD
Aminocaproic Acid—PLG—Hemostasis—GNA11—bone cancer	0.000907	0.0026	CbGpPWpGaD
Aminocaproic Acid—PLAT—Hemostasis—GNA11—bone cancer	0.000907	0.0026	CbGpPWpGaD
Aminocaproic Acid—Blood urea increased—Epirubicin—bone cancer	0.000889	0.0109	CcSEcCtD
Aminocaproic Acid—Pulmonary embolism—Doxorubicin—bone cancer	0.000872	0.0107	CcSEcCtD
Aminocaproic Acid—Injection site reaction—Doxorubicin—bone cancer	0.000866	0.0107	CcSEcCtD
Aminocaproic Acid—Tinnitus—Cisplatin—bone cancer	0.000859	0.0106	CcSEcCtD
Aminocaproic Acid—PLAT—Signaling by PDGF—MDM2—bone cancer	0.000856	0.00245	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling by PDGF—MDM2—bone cancer	0.000856	0.00245	CbGpPWpGaD
Aminocaproic Acid—AOX1—Metabolism—NDUFA12—bone cancer	0.000854	0.00245	CbGpPWpGaD
Aminocaproic Acid—Blood urea increased—Doxorubicin—bone cancer	0.000823	0.0101	CcSEcCtD
Aminocaproic Acid—PLAT—Hemostasis—IL3—bone cancer	0.000822	0.00235	CbGpPWpGaD
Aminocaproic Acid—PLG—Hemostasis—IL3—bone cancer	0.000822	0.00235	CbGpPWpGaD
Aminocaproic Acid—PLG—Metabolism of proteins—EIF2S1—bone cancer	0.000817	0.00234	CbGpPWpGaD
Aminocaproic Acid—PLAT—Senescence and Autophagy in Cancer—TP53—bone cancer	0.000763	0.00219	CbGpPWpGaD
Aminocaproic Acid—Anaphylactoid reaction—Methotrexate—bone cancer	0.000755	0.00929	CcSEcCtD
Aminocaproic Acid—Cerebrovascular accident—Methotrexate—bone cancer	0.000746	0.00917	CcSEcCtD
Aminocaproic Acid—Ill-defined disorder—Cisplatin—bone cancer	0.000744	0.00915	CcSEcCtD
Aminocaproic Acid—Malaise—Cisplatin—bone cancer	0.000723	0.0089	CcSEcCtD
Aminocaproic Acid—Leukopenia—Cisplatin—bone cancer	0.000718	0.00883	CcSEcCtD
Aminocaproic Acid—PLG—Extracellular matrix organization—MMP2—bone cancer	0.000715	0.00205	CbGpPWpGaD
Aminocaproic Acid—AOX1—Metabolism—NT5C3A—bone cancer	0.000708	0.00203	CbGpPWpGaD
Aminocaproic Acid—Anaphylactoid reaction—Epirubicin—bone cancer	0.000707	0.00869	CcSEcCtD
Aminocaproic Acid—Cerebrovascular accident—Epirubicin—bone cancer	0.000698	0.00859	CcSEcCtD
Aminocaproic Acid—Convulsion—Cisplatin—bone cancer	0.000695	0.00855	CcSEcCtD
Aminocaproic Acid—Myalgia—Cisplatin—bone cancer	0.000683	0.0084	CcSEcCtD
Aminocaproic Acid—Discomfort—Cisplatin—bone cancer	0.000675	0.0083	CcSEcCtD
Aminocaproic Acid—Oedema—Cisplatin—bone cancer	0.000654	0.00805	CcSEcCtD
Aminocaproic Acid—Anaphylactic shock—Cisplatin—bone cancer	0.000654	0.00805	CcSEcCtD
Aminocaproic Acid—Anaphylactoid reaction—Doxorubicin—bone cancer	0.000654	0.00804	CcSEcCtD
Aminocaproic Acid—Cerebrovascular accident—Doxorubicin—bone cancer	0.000646	0.00794	CcSEcCtD
Aminocaproic Acid—Thrombocytopenia—Cisplatin—bone cancer	0.000641	0.00788	CcSEcCtD
Aminocaproic Acid—Hypotension—Cisplatin—bone cancer	0.000612	0.00752	CcSEcCtD
Aminocaproic Acid—Muscular weakness—Epirubicin—bone cancer	0.000603	0.00742	CcSEcCtD
Aminocaproic Acid—Musculoskeletal discomfort—Cisplatin—bone cancer	0.000596	0.00734	CcSEcCtD
Aminocaproic Acid—PLG—Signaling by PDGF—EGFR—bone cancer	0.000585	0.00168	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling by PDGF—EGFR—bone cancer	0.000585	0.00168	CbGpPWpGaD
Aminocaproic Acid—Dyspnoea—Cisplatin—bone cancer	0.000583	0.00718	CcSEcCtD
Aminocaproic Acid—Pain—Cisplatin—bone cancer	0.00056	0.00689	CcSEcCtD
Aminocaproic Acid—Muscular weakness—Doxorubicin—bone cancer	0.000558	0.00687	CcSEcCtD
Aminocaproic Acid—Renal failure—Methotrexate—bone cancer	0.000554	0.00681	CcSEcCtD
Aminocaproic Acid—PLAT—Signaling Pathways—GRM4—bone cancer	0.00055	0.00158	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—RGS1—bone cancer	0.00055	0.00158	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—GRM4—bone cancer	0.00055	0.00158	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—RGS1—bone cancer	0.00055	0.00158	CbGpPWpGaD
Aminocaproic Acid—Feeling abnormal—Cisplatin—bone cancer	0.000539	0.00664	CcSEcCtD
Aminocaproic Acid—PLAT—Hemostasis—PLAU—bone cancer	0.000539	0.00154	CbGpPWpGaD
Aminocaproic Acid—PLG—Hemostasis—PLAU—bone cancer	0.000539	0.00154	CbGpPWpGaD
Aminocaproic Acid—PLG—Extracellular matrix organization—MMP9—bone cancer	0.000538	0.00154	CbGpPWpGaD
Aminocaproic Acid—Agranulocytosis—Methotrexate—bone cancer	0.000525	0.00647	CcSEcCtD
Aminocaproic Acid—Renal failure—Epirubicin—bone cancer	0.000518	0.00637	CcSEcCtD
Aminocaproic Acid—Agranulocytosis—Epirubicin—bone cancer	0.000492	0.00605	CcSEcCtD
Aminocaproic Acid—Hypersensitivity—Cisplatin—bone cancer	0.000482	0.00593	CcSEcCtD
Aminocaproic Acid—Bradycardia—Epirubicin—bone cancer	0.000482	0.00592	CcSEcCtD
Aminocaproic Acid—Renal failure—Doxorubicin—bone cancer	0.000479	0.0059	CcSEcCtD
Aminocaproic Acid—PLG—Signaling Pathways—GRM1—bone cancer	0.000477	0.00137	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—GRM1—bone cancer	0.000477	0.00137	CbGpPWpGaD
Aminocaproic Acid—Tinnitus—Methotrexate—bone cancer	0.000471	0.0058	CcSEcCtD
Aminocaproic Acid—Agranulocytosis—Doxorubicin—bone cancer	0.000455	0.0056	CcSEcCtD
Aminocaproic Acid—Diarrhoea—Cisplatin—bone cancer	0.000448	0.00551	CcSEcCtD
Aminocaproic Acid—Bradycardia—Doxorubicin—bone cancer	0.000446	0.00548	CcSEcCtD
Aminocaproic Acid—Tinnitus—Epirubicin—bone cancer	0.000441	0.00543	CcSEcCtD
Aminocaproic Acid—Vomiting—Cisplatin—bone cancer	0.000416	0.00512	CcSEcCtD
Aminocaproic Acid—Rash—Cisplatin—bone cancer	0.000413	0.00508	CcSEcCtD
Aminocaproic Acid—Dermatitis—Cisplatin—bone cancer	0.000412	0.00507	CcSEcCtD
Aminocaproic Acid—Ill-defined disorder—Methotrexate—bone cancer	0.000408	0.00502	CcSEcCtD
Aminocaproic Acid—Tinnitus—Doxorubicin—bone cancer	0.000408	0.00502	CcSEcCtD
Aminocaproic Acid—Malaise—Methotrexate—bone cancer	0.000397	0.00488	CcSEcCtD
Aminocaproic Acid—Leukopenia—Methotrexate—bone cancer	0.000394	0.00485	CcSEcCtD
Aminocaproic Acid—Nausea—Cisplatin—bone cancer	0.000389	0.00478	CcSEcCtD
Aminocaproic Acid—Ill-defined disorder—Epirubicin—bone cancer	0.000382	0.0047	CcSEcCtD
Aminocaproic Acid—Convulsion—Methotrexate—bone cancer	0.000381	0.00469	CcSEcCtD
Aminocaproic Acid—Myalgia—Methotrexate—bone cancer	0.000375	0.00461	CcSEcCtD
Aminocaproic Acid—Malaise—Epirubicin—bone cancer	0.000371	0.00457	CcSEcCtD
Aminocaproic Acid—AOX1—Disease—ENO2—bone cancer	0.00037	0.00106	CbGpPWpGaD
Aminocaproic Acid—Discomfort—Methotrexate—bone cancer	0.00037	0.00455	CcSEcCtD
Aminocaproic Acid—Syncope—Epirubicin—bone cancer	0.000369	0.00454	CcSEcCtD
Aminocaproic Acid—Leukopenia—Epirubicin—bone cancer	0.000369	0.00454	CcSEcCtD
Aminocaproic Acid—Confusional state—Methotrexate—bone cancer	0.000362	0.00446	CcSEcCtD
Aminocaproic Acid—Loss of consciousness—Epirubicin—bone cancer	0.000362	0.00445	CcSEcCtD
Aminocaproic Acid—Anaphylactic shock—Methotrexate—bone cancer	0.000359	0.00442	CcSEcCtD
Aminocaproic Acid—Convulsion—Epirubicin—bone cancer	0.000357	0.00439	CcSEcCtD
Aminocaproic Acid—Ill-defined disorder—Doxorubicin—bone cancer	0.000354	0.00435	CcSEcCtD
Aminocaproic Acid—Thrombocytopenia—Methotrexate—bone cancer	0.000352	0.00433	CcSEcCtD
Aminocaproic Acid—Myalgia—Epirubicin—bone cancer	0.000351	0.00431	CcSEcCtD
Aminocaproic Acid—Discomfort—Epirubicin—bone cancer	0.000346	0.00426	CcSEcCtD
Aminocaproic Acid—Malaise—Doxorubicin—bone cancer	0.000344	0.00423	CcSEcCtD
Aminocaproic Acid—AOX1—Disease—DHFR—bone cancer	0.000343	0.000984	CbGpPWpGaD
Aminocaproic Acid—Syncope—Doxorubicin—bone cancer	0.000342	0.0042	CcSEcCtD
Aminocaproic Acid—Leukopenia—Doxorubicin—bone cancer	0.000341	0.0042	CcSEcCtD
Aminocaproic Acid—Confusional state—Epirubicin—bone cancer	0.000339	0.00417	CcSEcCtD
Aminocaproic Acid—PLG—Signaling Pathways—SMO—bone cancer	0.000336	0.000963	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—SMO—bone cancer	0.000336	0.000963	CbGpPWpGaD
Aminocaproic Acid—Oedema—Epirubicin—bone cancer	0.000336	0.00413	CcSEcCtD
Aminocaproic Acid—Anaphylactic shock—Epirubicin—bone cancer	0.000336	0.00413	CcSEcCtD
Aminocaproic Acid—Hypotension—Methotrexate—bone cancer	0.000336	0.00413	CcSEcCtD
Aminocaproic Acid—Loss of consciousness—Doxorubicin—bone cancer	0.000335	0.00412	CcSEcCtD
Aminocaproic Acid—PLG—Metabolism of proteins—MMP2—bone cancer	0.000334	0.000958	CbGpPWpGaD
Aminocaproic Acid—Shock—Epirubicin—bone cancer	0.000331	0.00407	CcSEcCtD
Aminocaproic Acid—Convulsion—Doxorubicin—bone cancer	0.00033	0.00406	CcSEcCtD
Aminocaproic Acid—Thrombocytopenia—Epirubicin—bone cancer	0.000329	0.00405	CcSEcCtD
Aminocaproic Acid—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000327	0.00403	CcSEcCtD
Aminocaproic Acid—Myalgia—Doxorubicin—bone cancer	0.000324	0.00399	CcSEcCtD
Aminocaproic Acid—Discomfort—Doxorubicin—bone cancer	0.000321	0.00394	CcSEcCtD
Aminocaproic Acid—Dyspnoea—Methotrexate—bone cancer	0.00032	0.00394	CcSEcCtD
Aminocaproic Acid—Hypotension—Epirubicin—bone cancer	0.000314	0.00386	CcSEcCtD
Aminocaproic Acid—Confusional state—Doxorubicin—bone cancer	0.000314	0.00386	CcSEcCtD
Aminocaproic Acid—Anaphylactic shock—Doxorubicin—bone cancer	0.000311	0.00383	CcSEcCtD
Aminocaproic Acid—Oedema—Doxorubicin—bone cancer	0.000311	0.00383	CcSEcCtD
Aminocaproic Acid—AOX1—Metabolism—ENO2—bone cancer	0.00031	0.000888	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—GNA11—bone cancer	0.000307	0.000881	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—GNA11—bone cancer	0.000307	0.000881	CbGpPWpGaD
Aminocaproic Acid—Pain—Methotrexate—bone cancer	0.000307	0.00378	CcSEcCtD
Aminocaproic Acid—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000306	0.00377	CcSEcCtD
Aminocaproic Acid—Shock—Doxorubicin—bone cancer	0.000306	0.00376	CcSEcCtD
Aminocaproic Acid—Thrombocytopenia—Doxorubicin—bone cancer	0.000304	0.00375	CcSEcCtD
Aminocaproic Acid—Dyspnoea—Epirubicin—bone cancer	0.0003	0.00369	CcSEcCtD
Aminocaproic Acid—Feeling abnormal—Methotrexate—bone cancer	0.000296	0.00364	CcSEcCtD
Aminocaproic Acid—Gastrointestinal pain—Methotrexate—bone cancer	0.000294	0.00361	CcSEcCtD
Aminocaproic Acid—Hypotension—Doxorubicin—bone cancer	0.000291	0.00358	CcSEcCtD
Aminocaproic Acid—AOX1—Metabolism—DHFR—bone cancer	0.000288	0.000824	CbGpPWpGaD
Aminocaproic Acid—Pain—Epirubicin—bone cancer	0.000287	0.00354	CcSEcCtD
Aminocaproic Acid—PLAT—Signaling Pathways—ATF1—bone cancer	0.000286	0.000819	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—ATF1—bone cancer	0.000286	0.000819	CbGpPWpGaD
Aminocaproic Acid—Abdominal pain—Methotrexate—bone cancer	0.000284	0.00349	CcSEcCtD
Aminocaproic Acid—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000283	0.00349	CcSEcCtD
Aminocaproic Acid—PLG—Signaling Pathways—IL3—bone cancer	0.000279	0.000798	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—IL3—bone cancer	0.000279	0.000798	CbGpPWpGaD
Aminocaproic Acid—Dyspnoea—Doxorubicin—bone cancer	0.000277	0.00341	CcSEcCtD
Aminocaproic Acid—Feeling abnormal—Epirubicin—bone cancer	0.000277	0.00341	CcSEcCtD
Aminocaproic Acid—Gastrointestinal pain—Epirubicin—bone cancer	0.000275	0.00338	CcSEcCtD
Aminocaproic Acid—AOX1—Metabolism—GNA11—bone cancer	0.000269	0.00077	CbGpPWpGaD
Aminocaproic Acid—Pain—Doxorubicin—bone cancer	0.000266	0.00327	CcSEcCtD
Aminocaproic Acid—Abdominal pain—Epirubicin—bone cancer	0.000266	0.00327	CcSEcCtD
Aminocaproic Acid—Hypersensitivity—Methotrexate—bone cancer	0.000265	0.00326	CcSEcCtD
Aminocaproic Acid—Feeling abnormal—Doxorubicin—bone cancer	0.000256	0.00315	CcSEcCtD
Aminocaproic Acid—Gastrointestinal pain—Doxorubicin—bone cancer	0.000254	0.00313	CcSEcCtD
Aminocaproic Acid—Pruritus—Methotrexate—bone cancer	0.000254	0.00313	CcSEcCtD
Aminocaproic Acid—AOX1—Disease—TGFBR2—bone cancer	0.000249	0.000713	CbGpPWpGaD
Aminocaproic Acid—Hypersensitivity—Epirubicin—bone cancer	0.000248	0.00305	CcSEcCtD
Aminocaproic Acid—Abdominal pain—Doxorubicin—bone cancer	0.000246	0.00302	CcSEcCtD
Aminocaproic Acid—Diarrhoea—Methotrexate—bone cancer	0.000246	0.00302	CcSEcCtD
Aminocaproic Acid—AOX1—Metabolism—CYP3A4—bone cancer	0.000244	0.000698	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—TGFBR2—bone cancer	0.000238	0.000683	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—TGFBR2—bone cancer	0.000238	0.000683	CbGpPWpGaD
Aminocaproic Acid—Pruritus—Epirubicin—bone cancer	0.000238	0.00293	CcSEcCtD
Aminocaproic Acid—Dizziness—Methotrexate—bone cancer	0.000237	0.00292	CcSEcCtD
Aminocaproic Acid—Diarrhoea—Epirubicin—bone cancer	0.00023	0.00283	CcSEcCtD
Aminocaproic Acid—Hypersensitivity—Doxorubicin—bone cancer	0.000229	0.00282	CcSEcCtD
Aminocaproic Acid—Vomiting—Methotrexate—bone cancer	0.000228	0.00281	CcSEcCtD
Aminocaproic Acid—Rash—Methotrexate—bone cancer	0.000226	0.00279	CcSEcCtD
Aminocaproic Acid—Dermatitis—Methotrexate—bone cancer	0.000226	0.00278	CcSEcCtD
Aminocaproic Acid—Headache—Methotrexate—bone cancer	0.000225	0.00277	CcSEcCtD
Aminocaproic Acid—PLG—Signaling Pathways—IGF1R—bone cancer	0.000224	0.000642	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—IGF1R—bone cancer	0.000224	0.000642	CbGpPWpGaD
Aminocaproic Acid—Dizziness—Epirubicin—bone cancer	0.000222	0.00273	CcSEcCtD
Aminocaproic Acid—Pruritus—Doxorubicin—bone cancer	0.00022	0.00271	CcSEcCtD
Aminocaproic Acid—PLAT—Hemostasis—TP53—bone cancer	0.000217	0.000621	CbGpPWpGaD
Aminocaproic Acid—PLG—Hemostasis—TP53—bone cancer	0.000217	0.000621	CbGpPWpGaD
Aminocaproic Acid—Vomiting—Epirubicin—bone cancer	0.000214	0.00263	CcSEcCtD
Aminocaproic Acid—Nausea—Methotrexate—bone cancer	0.000213	0.00262	CcSEcCtD
Aminocaproic Acid—Diarrhoea—Doxorubicin—bone cancer	0.000213	0.00262	CcSEcCtD
Aminocaproic Acid—Rash—Epirubicin—bone cancer	0.000212	0.00261	CcSEcCtD
Aminocaproic Acid—Dermatitis—Epirubicin—bone cancer	0.000212	0.0026	CcSEcCtD
Aminocaproic Acid—Headache—Epirubicin—bone cancer	0.000211	0.00259	CcSEcCtD
Aminocaproic Acid—AOX1—Metabolism—GSTP1—bone cancer	0.000208	0.000597	CbGpPWpGaD
Aminocaproic Acid—Dizziness—Doxorubicin—bone cancer	0.000206	0.00253	CcSEcCtD
Aminocaproic Acid—Nausea—Epirubicin—bone cancer	0.0002	0.00246	CcSEcCtD
Aminocaproic Acid—Vomiting—Doxorubicin—bone cancer	0.000198	0.00243	CcSEcCtD
Aminocaproic Acid—Rash—Doxorubicin—bone cancer	0.000196	0.00241	CcSEcCtD
Aminocaproic Acid—Dermatitis—Doxorubicin—bone cancer	0.000196	0.00241	CcSEcCtD
Aminocaproic Acid—Headache—Doxorubicin—bone cancer	0.000195	0.0024	CcSEcCtD
Aminocaproic Acid—Nausea—Doxorubicin—bone cancer	0.000185	0.00227	CcSEcCtD
Aminocaproic Acid—AOX1—Disease—KIT—bone cancer	0.00017	0.000486	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—KIT—bone cancer	0.000163	0.000466	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—KIT—bone cancer	0.000163	0.000466	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—BRAF—bone cancer	0.00016	0.000457	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—BRAF—bone cancer	0.000153	0.000438	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—BRAF—bone cancer	0.000153	0.000438	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—MDM2—bone cancer	0.000134	0.000383	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—PTGS2—bone cancer	0.000129	0.000369	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—MDM2—bone cancer	0.000128	0.000367	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—MDM2—bone cancer	0.000128	0.000367	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—JUN—bone cancer	0.000111	0.000319	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—JUN—bone cancer	0.000111	0.000319	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—MMP9—bone cancer	0.000108	0.00031	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—MMP9—bone cancer	0.000108	0.00031	CbGpPWpGaD
Aminocaproic Acid—AOX1—Metabolism—PTGS2—bone cancer	0.000108	0.000309	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—EGFR—bone cancer	9.14e-05	0.000262	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—EGFR—bone cancer	8.75e-05	0.000251	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—EGFR—bone cancer	8.75e-05	0.000251	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—TP53—bone cancer	7.35e-05	0.000211	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—TP53—bone cancer	7.35e-05	0.000211	CbGpPWpGaD
